COVID-19 PCR Test Results in Asymptomatic Pregnants
Sponsor
Istanbul Medipol University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04410939
Collaborator
(none)
179
1
1.3
132.9
Study Details
Study Description
Brief Summary
In order to prevent contamination from the pregnant women hospitalized in this clinic, the RT-PCR test is performed from the oropharyngeal and nasal swab sample taken before hospitalization. In addition, the same test is done before each operation and before the operation. The aim of the study is to scan these tests retrospectively and to determine the rate of positive COVID-19 cases in asymptomatic pregnant women. The results will determine the importance of the measures to be taken in the pregnant women who undergo intervention.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
179 participants
Observational Model:
Case-Crossover
Time Perspective:
Retrospective
Official Title:
COVID-19 PCR Test Results in Asymptomatic Pregnants Admitted for Birth and Other Interventions in Our Clinic
Actual Study Start Date
:
Apr 10, 2020
Actual Primary Completion Date
:
May 20, 2020
Actual Study Completion Date
:
May 21, 2020
Outcome Measures
Primary Outcome Measures
- Rate of positive COVID-19 cases in asymptomatic pregnant women [1 day]
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Asymptomatic pregnant women who will give birth in this clinic, dilatation and curettage due to missed abortion, cerclage due to cervical insufficiency, medical evacuation due to fetal anomaly, and routine PCR test taken for service for some treatments.
Exclusion Criteria:
- Having any COVID-19 infection symptoms (fever, cough, weakness, shortness of breath, sore throat, etc.)
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Istanbul Medipol University | Istanbul | Turkey |
Sponsors and Collaborators
- Istanbul Medipol University Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
Responsible Party:
Istanbul Medipol University Hospital
ClinicalTrials.gov Identifier:
NCT04410939
Other Study ID Numbers:
- Gpolat1
First Posted:
Jun 1, 2020
Last Update Posted:
Jun 1, 2020
Last Verified:
May 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: